NYSE (USA) TSX (CANADA)

Directory of Stock Market Company

This site is a directory of Stock Market Company in USA and Canada. Each company page contains a description, stock quote, news and much more. You have also access to the best stock market game on the web.

Search into NYSE and TSX
by quote, company name or key word

facebooktwitterlinkedin
Mail

ACUR - Acura Pharmaceuticals Inc

Acura Pharmaceuticals, Inc. is a specialty pharmaceutical company engaged in research, development and manufacture of product candidates providing abuse deterrent features and benefits utilizing its Aversion and Impede Technologies. The Company’s Aversion Technology platform has been utilized in developing multiple opioid analgesic products candidates. Its portfolio","NYSE, Nasdaq, S&P, trading, US market, Asian market, Dow Jones, FTSE, DJIA, DAX, stocks, bonds, shares","Connect to the most current information on stocks and bonds on Reuters.com. What you need to know now about NYSE, Dow Jones, S&P, and Nasdaq at Reuters.com"

# ACURhart

Acura Pharmaceuticals Inc News


Acura Pharmaceuticals Announces First Quarter 2012 Financial Results
MarketWatch (press release) - May 1, 2012
PALATINE, IL, May 01, 2012 (MARKETWIRE via COMTEX) -- Acura Pharmaceuticals, Inc. (UTD:ACUR) , a specialty pharmaceutical company developing products intended to address medication abuse and misuse, announced today financial results for the three ...

Kahn Swick & Foti, LLC Announces Class Action Settlement On Behalf Of Purchasers Of Publicly-Traded Securities Of Acura Pharmaceuticals Inc.
Reuters Key Development - Nov 28, 2011

Acura Pharmaceuticals Inc Secures U.S. Patent For Abuse Deterrent Drug Formulations
Reuters Key Development - Sep 27, 2011

Acura Pharmaceuticals Inc Appoints New President And CEO
Reuters Key Development - Jul 11, 2011

Pfizer And Acura Pharmaceuticals, Inc. Announce FDA Approval Of Oxectatm (Oxycodone HCL, USP) CII
Reuters Key Development - Jun 20, 2011

Acura Pharmaceuticals, Inc. Announces Board Changes
Reuters Key Development - May 2, 2011

Acura Pharmaceuticals, Inc. Announces Andrew Reddick, President & CEO, To Take Medical Leave - Form 8K
Reuters Key Development - Apr 25, 2011

Acura Pharmaceuticals, Inc. Announces It Has Been Informed By King Pharmaceuticals Research and Development Inc. That King's NDA For ACUROX (oxycodone HCl) Tablets Was Accepted For Filing By US FDA
Reuters Key Development - Feb 14, 2011

King Pharmaceuticals, Inc. And Acura Pharmaceuticals, Inc. Announce Submission Of New Drug Application For ACUROX Tablets
Reuters Key Development - Dec 20, 2010

The Shuman Law Firm Announces Filing Of Class Action Lawsuit Against Acura Pharmaceuticals, Inc.
Reuters Key Development - Oct 21, 2010

NYSE Media Coverage Selection of the best articles found in your favorit medias

Next Company >>